Six Firms Advise on First Pharmaceutical Megadeal of 2016

Cravath, Jones Day, Kirkland & Ellis, Ropes & Gray, Slaughter and May and Skadden have grabbed roles on the proposed $32 billion merger between rare disease drug makers Shire plc and Baxalta Inc.

YOUR COMPLIMENTARY 15-DAY LAW.COM TRIAL HAS ENDED.
Subscribe now to continue reading →

To continue reading, upgrade and become a Law.com subscriber.
Get 2 MONTHS FREE when you sign up for a 12 month subscription.